|
1
|
Dohan DM, Choukroun J, Diss A, Dohan SL,
Dohan AJ, Mouhyi J and Gogly B: Platelet-rich fibrin (PRF): A
second-generation platelet concentrate. Part II: Platelet-related
biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 101:e45–e50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Senzel L, Gnatenko DV and Bahou WF: The
platelet proteome. Curr Opin Hematol. 16:329–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whitman DH, Berry RL and Green DM:
Platelet gel: An autologous alternative to fibrin glue with
applications in oral and maxillofacial surgery. J Oral Maxillofac
Surg. 55:1294–1299. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vaishnavi C, Mohan B and Narayanan LL:
Treatment of endodontically induced periapical lesions using
hydroxyapatite, platelet-rich plasma, and a combination of both: An
in vivo study. J Conserv Dent. 14:140–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta C, Mehrotra D, Mohammad S, Khanna V,
Kumar Singh G, Singh G, Chellappa AA and Passi D: Alveolar bone
graft with platelet rich plasma in cleft alveolus. J Oral Biol
Craniofac Res. 3:3–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawase T: Platelet-rich plasma and its
derivatives as promising bioactive materials for regenerative
medicine: Basic principles and concepts underlying recent advances.
Odontology. 103:126–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dohan DM, Choukroun J, Diss A, Dohan SL,
Dohan AJ, Mouhyi J and Gogly B: Platelet-rich fibrin (PRF): A
second-generation platelet concentrate. Part I: Technological
concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 101:e37–e44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodella LF, Favero G, Boninsegna R,
Buffoli B, Labanca M, Scari G, Sacco L, Batani T and Rezzani R:
Growth factors, CD34 positive cells, and fibrin network analysis in
concentrated growth factors fraction. Microsc Res Tech. 74:772–777.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Durmuşlar MC, Balli U, Dede FÖ, Misir AF,
Bariş E, Kürkçü M and Kahraman SA: Histological evaluation of the
effect of concentrated growth factor on bone healing. J Craniofac
Surg. 27:1494–1497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su CY, Kuo YP, Tseng YH, Su CH and Burnouf
T: In vitro release of growth factors from platelet-rich fibrin
(PRF): A proposal to optimize the clinical applications of PRF.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 108:56–61. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raggatt LJ and Partridge NC: Cellular and
molecular mechanisms of bone remodeling. J Biol Chem.
285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Franceschi RT and Iyer BS: Relationship
between collagen synthesis and expression of the osteoblast
phenotype in MC3T3-E1 cells. J Bone Miner Res. 7:235–246. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spelsberg TC, Subramaniam M, Riggs BL and
Khosla S: The actions and interactions of sex steroids and growth
factors/cytokines on the skeleton. Mol Endocrinol. 13:819–828.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maeda T, Matsunuma A, Kawane T and
Horiuchi N: Simvastatin promotes osteoblast differentiation and
mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun.
280:874–877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu M, Chen G and Li YP: TGF-β and BMP
signaling in osteoblast, skeletal development, and bone formation,
homeostasis and disease. Bone Res. 4:160092016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sparks AB, Morin PJ, Vogelstein B and
Kinzler KW: Mutational analysis of the APC/beta-catenin/Tcf pathway
in colorectal cancer. Cancer Res. 58:1130–1134. 1998.PubMed/NCBI
|
|
17
|
Dejmek J, Säfholm A, Kamp Nielsen C,
Andersson T and Leandersson K: Wnt-5a/Ca2+-induced NFAT
activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha
signaling in human mammary epithelial cells. Mol Cell Biol.
26:6024–6036. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin SS, Ueng SW, Niu CC, Yuan LJ, Yang CY,
Chen WJ, Lee MS and Chen JK: Hyperbaric oxygen promotes osteogenic
differentiation of bone marrow stromal cells by regulating
Wnt3a/β-catenin signaling-an in vitro and in vivo study. Stem Cell
Res. 12:260–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krause U, Harris S, Green A, Ylostalo J,
Zeitouni S, Lee N and Gregory CA: Pharmaceutical modulation of
canonical Wnt signaling in multipotent stromal cells for improved
osteoinductive therapy. Proc Natl Acad Sci USA. 107:4147–4152.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anderson DM, Maraskovsky E, Billingsley
WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D
and Galibert L: A homologue of the TNF receptor and its ligand
enhance T-cell growth and dendritic-cell function. Nature.
390:175–179. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sato MM, Nakashima A, Nashimoto M, Yawaka
Y and Tamura M: Bone morphogenetic protein-2 enhances
Wnt/beta-catenin signaling-induced osteoprotegerin expression.
Genes Cells. 14:141–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang IC, Tsai CH and Chang YC:
Platelet-rich fibrin modulates the expression of extracellular
signal-regulated protein kinase and osteoprotegerin in human
osteoblasts. J Biomed Mater Res A. 95:327–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rogers A, Saleh G, Hannon RA, Greenfield D
and Eastell R: Circulating estradiol and osteoprotegerin as
determinants of bone turnover and bone density in postmenopausal
women. J Clin Endocrinol Metab. 87:4470–4475. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maeda T, Suzuki A, Yuzawa S, Baba Y,
Kimura Y and Kato Y: Mineral trioxide aggregate induces
osteoblastogenesis via Atf6. Bone Rep. 2:36–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim TH, Kim SH, Sándor GK and Kim YD:
Comparison of platelet-rich plasma (PRP), platelet-rich fibrin
(PRF), and concentrated growth factor (CGF) in rabbit-skull defect
healing. Arch Oral Biol. 59:550–558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fukui N, Ueno T, Ito Y, Takahashi Y,
Kimura Y, Nakajima Y, Kasuya S, Kanou M, Takubo K, Yamamoto K, et
al: Quantification of growth factors in platelet-rich Fibrin: A
preliminary study. J Hard Tissue Biol. 24:231–234. 2015. View Article : Google Scholar
|
|
27
|
Ogino Y, Ayukawa Y, Kukita T, Atsuta I and
Koyano K: Platelet-rich plasma suppresses osteoclastogenesis by
promoting the secretion of osteoprotegerin. J Periodontal Res.
44:217–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khadra M, Kasem N, Haanaes HR, Ellingsen
JE and Lyngstadaas SP: Enhancement of bone formation in rat
calvarial bone defects using low-level laser therapy. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 97:693–700. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choukroun J, Diss A, Simonpieri A, Girard
MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J and Dohan DM:
Platelet-rich fibrin (PRF): A second-generation platelet
concentrate. Part IV: Clinical effects on tissue healing. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 101:e56–e60. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pripatnanont P, Nuntanaranont T,
Vongvatcharanon S and Phurisat K: The primacy of platelet-rich
fibrin on bone regeneration of various grafts in rabbit's calvarial
defects. J Craniomaxillofac Surg. 41:e191–e200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamazaki T, Tetsuya K and Yokose S:
Histological demonstration of bone healing in rat tibiae influenced
by diode laser irradiation. J Japan Soc Laser Surg Med. 37:80–86.
2016.
|
|
32
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: A novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yasuda H, Shima N, Nakagawa N, Yamaguchi
K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A,
et al: Osteoclast differentiation factor is a ligand for
osteoprotegerin/osteoclastogenesis-inhibitory factor and is
identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:3597–3602.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang X, Wang Y, Han X, Shu R, Chen T, Zeng
H, Xu X, Huang L, Ren A, Song J, et al: Effects of TGF-β1 on
OPG/RANKL expression of cementoblasts and osteoblasts are similar
without stress but different with mechanical compressive stress.
Scientific World Journal. 2015:7181802015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baek KJ, Choi Y and Ji S: Gingival
fibroblasts from periodontitis patients exhibit inflammatory
characteristics in vitro. Arch Oral Biol. 58:1282–1292. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gautam J, Khedgikar V, Choudhary D,
Kushwaha P, Dixit P, Singh D, Maurya R and Trivedi R: An isoflavone
cladrin prevents high-fat diet-induced bone loss and inhibits the
expression of adipogenic gene regulators in 3T3-L1 adipocyte. J
Pharm Pharmacol. 68:1051–1063. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Songia P, Branchetti E, Parolari A,
Myasoedova V, Ferrari G, Alamanni F, Tremoli E and Poggio P: Mitral
valve endothelial cells secrete osteoprotegerin during endothelial
mesenchymal transition. J Mol Cell Cardiol. 98:48–57. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sahni A and Francis CW: Vascular
endothelial growth factor binds to fibrinogen and fibrin and
stimulates endothelial cell proliferation. Blood. 96:3772–3778.
2000.PubMed/NCBI
|
|
39
|
van Hinsbergh VW, Collen A and Koolwijk P:
Role of fibrin matrix in angiogenesis. Ann NY Acad Sci.
936:426–437. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tajima N, Ohba S, Sawase T and Asahina I:
Evaluation of sinus floor augmentation with simultaneous implant
placement using platelet-rich fibrin as sole grafting material. Int
J Oral Maxillofac Implants. 28:77–83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choukroun J, Diss A, Simonpieri A, Girard
MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J and Dohan DM:
Platelet-rich fibrin (PRF): A second-generation platelet
concentrate. Part V: Histologic evaluations of PRF effects on bone
allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 101:299–303. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Takeda Y, Katsutoshi K, Matsuzaka K and
Inoue T: The effect of concentrated growth factor on rat bone
marrow cells in vitro and on calvarial bone healing in vivo. Int J
Oral Maxillofac Implants. 30:1187–1196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Litvinov RI and Weisel JW: What is the
biological and clinical relevance of fibrin? Semin Thromb Hemost.
42:333–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Marx RE, Carlson ER, Eichstaedt RM,
Schimmele SR, Strauss JE and Georgeff KR: Platelet-rich plasma:
Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 85:638–646. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Plachokova AS, Nikolidakis D, Mulder J,
Jansen JA and Creugers NH: Effect of platelet-rich plasma on bone
regeneration in dentistry: A systematic review. Clin Oral Implants
Res. 19:539–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roffi A, Di Matteo B, Krishnakumar GS, Kon
E and Filardo G: Platelet-rich plasma for the treatment of bone
defects: From pre-clinical rational to evidence in the clinical
practice. A systematic review. Int Orthop. 41:221–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Broggini N, Hofstetter W, Hunziker E,
Bosshardt DD, Bornstein MM, Seto I, Weibrich G and Buser D: The
influence of PRP on early bone formation in membrane protected
defects. A histological and histomorphometric study in the rabbit
calvaria. Clin Implant Dent Relat Res. 13:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Simonpieri A, Del Corso M, Vervelle A,
Jimbo R, Inchingolo F, Sammartino G and Dohan Ehrenfest DM: Current
knowledge and perspectives for the use of platelet-rich plasma
(PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial
surgery part 2: Bone graft, implant and reconstructive surgery.
Curr Pharm Biotechnol. 13:1231–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Quarles LD, Yohay DA, Lever LW, Caton R
and Wenstrup RJ: Distinct proliferative and differentiated stages
of murine MC3T3-E1 cells in culture: An in vitro model of
osteoblast development. J Bone Miner Res. 7:683–692. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li F, Yang Y, Zhu P, Chen W, Qi D, Shi X,
Zhang C, Yang Z and Li P: Echinacoside promotes bone regeneration
by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia.
83:1443–1450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen X, Garner SC, Quarles LD and Anderson
JJ: Effects of genistein on expression of bone markers during
MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem.
14:342–349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gori F, Hofbauer LC, Dunstan CR, Spelsberg
TC, Khosla S and Riggs BL: The expression of osteoprotegerin and
RANK ligand and the support of osteoclast formation by
stromal-osteoblast lineage cells is developmentally regulated.
Endocrinology. 141:4768–4776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Clark RA: Fibrin and wound healing. Ann NY
Acad Sci. 936:355–367. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Intini G: The use of platelet-rich plasma
in bone reconstruction therapy. Biomaterials. 30:4956–4966. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Anitua E, Andia I, Ardanza B, Nurden P and
Nurden AT: Autologous platelets as a source of proteins for healing
and tissue regeneration. Thromb Haemost. 91:4–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Marques LF, Stessuk T, Camargo IC, Sabeh
Junior N, dos Santos L and Ribeiro-Paes JT: Platelet-rich plasma
(PRP): Methodological aspects and clinical applications. Platelets.
26:101–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Silva I and Branco JC: Rank/Rankl/opg:
Literature review. Acta Reumatol Port. 36:209–218. 2011.PubMed/NCBI
|
|
58
|
McCarthy HS, Williams JH, Davie MW and
Marshall MJ: Platelet-derived growth factor stimulates
osteoprotegerin production in osteoblastic cells. J Cell Physiol.
218:350–354. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ikebuchi Y, Aoki S, Honma M, Hayashi M,
Sugamori Y, Khan M, Kariya Y, Kato G, Tabata Y, Penninger JM, et
al: Coupling of bone resorption and formation by RANKL reverse
signalling. Nature. 561:195–200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fei Q, Guo C, Xu X, Gao J, Zhang J, Chen T
and Cui D: Osteogenic growth peptide enhances the proliferation of
bone marrow mesenchymal stem cells from osteoprotegerin-deficient
mice by CDK2/cyclin A. Acta Biochim Biophys Sin (Shanghai).
42:801–806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kapse S, Surana S, Satish M, Hussain SE,
Vyas S and Thakur D: Autologous platelet-rich fibrin: Can it secure
a better healing? Oral Surg Oral Med Oral Pathol Oral Radiol.
127:8–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
